Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Merck to develop Vical technology for therapeutic vaccines

Nov. 7, 1997

Heat shock proteins: a new vaccine strategy

Nov. 6, 1997

New human rabies vaccine cleared in U.S.

Nov. 4, 1997

Novel class of compound enhances IFN-gamma and NT-3 activity

Nov. 4, 1997

ID Vaccine and the NIAID collaborate on GAS vaccine

Oct. 31, 1997

Gene therapy approach to preventing organ transplant complication explored

Oct. 29, 1997

VZIG study in postherpetic neuralgia stopped; chickenpox study continues

Oct. 28, 1997

NIH awards Vaxcel two grants for vaccine research

Oct. 28, 1997

Promising preliminary results reported from pertussis vaccine project

Oct. 27, 1997

First report of efficacy for rotavirus vaccine in a developing country

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.